De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Thyrocare Technologies Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Thyrocare Technologies heeft een totaal eigen vermogen van ₹5.3B en een totale schuld van ₹423.4M, wat de schuld-eigenvermogensverhouding op 8% brengt. De totale activa en totale passiva bedragen respectievelijk ₹6.4B en ₹1.2B. De EBIT Thyrocare Technologies is ₹970.2M waardoor de rentedekking 22.5 is. Het heeft contanten en kortetermijnbeleggingen van ₹1.8B.
Belangrijke informatie
8.0%
Verhouding schuld/eigen vermogen
₹423.40m
Schuld
| Rente dekkingsratio | 22.5x |
| Contant | ₹1.80b |
| Aandelen | ₹5.28b |
| Totaal verplichtingen | ₹1.16b |
| Totaal activa | ₹6.44b |
Recente financiële gezondheidsupdates
Recent updates
Thyrocare Technologies Limited (NSE:THYROCARE) Looks Just Right With A 26% Price Jump
Aug 01
Thyrocare Technologies Limited (NSE:THYROCARE) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Jul 26A Look At The Fair Value Of Thyrocare Technologies Limited (NSE:THYROCARE)
Jun 12Getting In Cheap On Thyrocare Technologies Limited (NSE:THYROCARE) Might Be Difficult
Feb 29Revenue Miss: Thyrocare Technologies Limited Fell 10.0% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 04Here's Why Thyrocare Technologies (NSE:THYROCARE) Can Manage Its Debt Responsibly
Dec 08Why Thyrocare Technologies' (NSE:THYROCARE) Shaky Earnings Are Just The Beginning Of Its Problems
Nov 08Thyrocare Technologies (NSE:THYROCARE) Knows How To Allocate Capital Effectively
Mar 23Thyrocare Technologies Limited (NSE:THYROCARE) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Mar 02Investors In Thyrocare Technologies Limited (NSE:THYROCARE) Should Consider This, First
Feb 01Investors Who Bought Thyrocare Technologies (NSE:THYROCARE) Shares A Year Ago Are Now Up 81%
Jan 12
The Chairman & MD of Thyrocare Technologies Limited (NSE:THYROCARE), Velumani Arokiaswamy, Just Bought A Few More Shares
Dec 24Under The Bonnet, Thyrocare Technologies' (NSE:THYROCARE) Returns Look Impressive
Dec 17Thyrocare Technologies Limited's (NSE:THYROCARE) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Nov 30Analyst Forecasts For Thyrocare Technologies Limited (NSE:THYROCARE) Are Surging Higher
Nov 02Earnings Update: Thyrocare Technologies Limited (NSE:THYROCARE) Just Reported And Analysts Are Boosting Their Estimates
Nov 01How Does Thyrocare Technologies Limited (NSE:THYROCARE) Fare As A Dividend Stock?
Oct 28Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( ₹2.8B ) THYROCARE } overtreffen de korte termijn passiva ( ₹904.8M ).
Langlopende schulden: De kortetermijnactiva THYROCARE ( ₹2.8B ) overtreffen de langetermijnschulden ( ₹257.7M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: THYROCARE heeft meer geld in kas dan de totale schuld.
Schuld verminderen: De schuld/eigen vermogen-ratio van THYROCARE is de afgelopen 5 jaar gestegen van 0.6% naar 8%.
Schuldendekking: De schuld van THYROCARE wordt goed gedekt door de operationele kasstroom ( 395.9% ).
Rentedekking: De rentebetalingen op de schuld van THYROCARE worden goed gedekt door EBIT ( 22.5 x dekking).